The manufacturer of the TrioMed Active Technology which deactivates COVID-19 receives Gold medal at 2020 Canadian Industry Leadership Honours
MIRABEL, QC, Canada, Sept. 22, 2020 /CNW Telbec/ - The TrioMed Active technology manufacturer, i3 BioMedical inc., received the 2020 Gold Medal from the prestigious Canadian Industry Leadership Honours.
The Honorable Navdeep Bains, Federal Minister of Innovation, Science & Industry of Canada, welcomed attendees at the awards ceremony.
Selected from Canadian manufacturers responding to the COVID-19 pandemic, the TrioMed Active technology manufacturer was awarded the Gold medal for its innovative Self-Cleaning Antimicrobial facemask in the category: Canadian Company that made the most significant/novel impact on Canada's Personnel protective equipment.
About i3 BioMedical Inc: i3 BioMedical is a Canadian company, focused on the development and manufacturing of novel antimicrobial products that help prevent the spread of infection and disease.
Fitness International, LLC opened a new Club Studio location in Kingwood, Texas. The new 40,000 square foot club features five innovative boutique fitness studios that were carefully curated to create a unique experience, along with recovery services...
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary Inhibrx Biosciences, Inc. ("SpinCo") to holders of shares of...
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announces that, further to its news releases dated April 17, 2024, April 26, 2024, and May 8, 2024, the Management Cease Trade Order ("MCTO") issued by the...
The following statement is being issued by Rice Harbut Elliott LLP regarding the Ruckman v. Biotrade Canada Ltd. et al. lawsuit:
All persons in Canada who purchased or ingested U-Dream on or after August 18, 2014 (the "Class" or "Class Members")...
